Viral Infection Triggers Central Nervous System Autoimmunity Via Activation of Dual TCR-Expressing CD8+ T Cells

Multiple sclerosis is an inflammatory, demyelinating, central nervous system disease mediated by myelin-specific T cells. Environmental triggers that cause the breakdown of myelin-specific T cell tolerance are unknown. Here we found that CD8+ myelin basic protein (MBP)-specific T cell tolerance was broken and autoimmunity was induced by infection with a virus that did not express MBP cross-reactive epitopes and did not depend on bystander activation. Instead, the virus activated T cells expressing dual T cell antigen receptors (TCRs) that were able to recognize both MBP and viral antigens. Our results demonstrate the importance of dual TCR–expressing T cells in autoimmunity and suggest a mechanism by which a ubiquitous viral infection could trigger autoimmunity in a subset of infected people, as suggested by the etiology of multiple sclerosis.

[1]  S. Cook,et al.  Multiple sclerosis and viruses , 1980, Neurology.

[2]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[3]  Y. Uematsu,et al.  Exclusion and inclusion of α and β T cell receptor alleles , 1992, Cell.

[4]  Y. Uematsu,et al.  Exclusion and inclusion of alpha and beta T cell receptor alleles. , 1992, Cell.

[5]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[6]  J. Miller,et al.  Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice , 1993, The Journal of experimental medicine.

[7]  A. Lanzavecchia,et al.  Expression of two T cell receptor alpha chains: dual receptor T cells. , 1993, Science.

[8]  J. Kurtzke Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.

[9]  Susumu Tonegawa,et al.  High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.

[10]  D. Altmann,et al.  Dual T cell receptor alpha chain T cells in autoimmunity , 1995, The Journal of experimental medicine.

[11]  M. Bonneville,et al.  Dual T cell receptor beta chain expression on human T lymphocytes , 1995, The Journal of experimental medicine.

[12]  A. Lanzavecchia,et al.  Dual Receptor T‐Cells , 1995, Annals of the New York Academy of Sciences.

[13]  J. Miller,et al.  Expression of two T cell receptor alpha chains on the surface of normal murine T cells. , 1995, European journal of immunology.

[14]  A. Lanzavecchia,et al.  Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion , 1995, The Journal of experimental medicine.

[15]  R. Balderas,et al.  Incomplete T cell receptor V beta allelic exclusion and dual V beta-expressing cells. , 1995, Journal of immunology.

[16]  W. Heath,et al.  Expression of two T cell receptor α chains on the surface of normal murine T cells , 1995 .

[17]  L. Matis,et al.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. , 1996, The Journal of clinical investigation.

[18]  S. Miller,et al.  Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading , 1997, Nature Medicine.

[19]  H. D. Liggitt,et al.  Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. , 1997, Journal of immunology.

[20]  T. Barrett,et al.  Functional differentiation of T cells in the intestine of T cell receptor transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Gascoigne,et al.  Posttranslational regulation of TCR Valpha allelic exclusion during T cell differentiation. , 1998, Journal of immunology.

[22]  N. Gascoigne,et al.  Posttranslational regulation of TCR Valpha allelic exclusion during T cell differentiation. , 1998, Journal of immunology.

[23]  T. Hunkapiller,et al.  Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. , 1998, Immunity.

[24]  J. Lafaille,et al.  Regulatory Cd4 Ϩ T Cells Expressing Endogenous T Cell Receptor Chains Protect Myelin Basic Protein–specific Transgenic Mice from Spontaneous Autoimmune Encephalomyelitis , 1998 .

[25]  R. Sobel,et al.  Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice , 1999, Journal of Neuroimmunology.

[26]  S. Miller,et al.  A virus-induced molecular mimicry model of multiple sclerosis , 2001 .

[27]  Kutty Selva Nandakumar,et al.  Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in autoimmunity. , 2001, Journal of autoimmunity.

[28]  C. Janeway,et al.  Dual receptor T cells extend the immune repertoire for foreign antigens , 2002, Nature Immunology.

[29]  S. Miller,et al.  Epitope spreading in immune-mediated diseases: implications for immunotherapy , 2002, Nature Reviews Immunology.

[30]  Jacques F. A. P. MiUer Expression of Two Chains on the Surface of T Cells in T Cell Receptor Transgenic Mice , 2003 .

[31]  Nitin J. Karandikar,et al.  High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. , 2004, Blood.

[32]  J. Goverman,et al.  CD8+ T cells maintain tolerance to myelin basic protein by 'epitope theft' , 2004, Nature Immunology.

[33]  L. Fugger,et al.  Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? , 2005, Brain : a journal of neurology.

[34]  J. Goverman,et al.  The role of CD8(+) T cells in multiple sclerosis and its animal models. , 2005, Current drug targets. Inflammation and allergy.

[35]  R. Fujinami,et al.  Central Nervous System Pathology Caused by Autoreactive CD8+ T-Cell Clones following Virus Infection , 2005, Journal of Virology.

[36]  G. Cutter,et al.  Infectious causes of multiple sclerosis , 2006, The Lancet Neurology.

[37]  S. Miller,et al.  Structural requirements for initiation of cross‐reactivity and CNS autoimmunity with a PLP139–151 mimic peptide derived from murine hepatitis virus , 2006, European journal of immunology.

[38]  A. Ascherio,et al.  Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.

[39]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[40]  P. Sørensen,et al.  Multiple sclerosis after infectious mononucleosis. , 2007, Archives of neurology.

[41]  J. Goverman,et al.  Regulatory T Cells Maintain Long-Term Tolerance to Myelin Basic Protein by Inducing a Novel, Dynamic State of T Cell Tolerance1 , 2007, The Journal of Immunology.

[42]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[43]  J. Lünemann,et al.  Epstein-Barr virus and multiple sclerosis , 2007, Current neurology and neuroscience reports.

[44]  L. Fugger,et al.  Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis , 2008, Nature Network Boston.

[45]  P. Greenberg,et al.  Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. , 2008, Immunity.

[46]  J. Rioux,et al.  Integrating risk factors , 2008, Neurology.

[47]  J. Goverman,et al.  Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells , 2008, Nature Medicine.

[48]  K. Selmaj,et al.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. , 2008, The New England journal of medicine.

[49]  R. Lucas Faculty Opinions recommendation of Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. , 2008 .

[50]  F. Schmidt Meta-Analysis , 2008 .

[51]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[52]  G. Giovannoni,et al.  Epstein–Barr virus and multiple sclerosis , 2009, Current opinion in neurology.

[53]  T. Lane,et al.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System. , 2009, Current immunology reviews.

[54]  G. Khan,et al.  Epstein-Barr Virus in Multiple Sclerosis , 2019, Multiple Sclerosis [Working Title].

[55]  P. Allen,et al.  Cutting Edge: Highly Alloreactive Dual TCR T Cells Play a Dominant Role in Graft-versus-Host Disease1 , 2009, The Journal of Immunology.

[56]  D. Hafler,et al.  Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. , 2009, Brain : a journal of neurology.

[57]  J. Lünemann,et al.  Antiviral immune responses: triggers of or triggered by autoimmunity? , 2009, Nature Reviews Immunology.

[58]  A. Ascherio,et al.  Epstein–Barr Virus Infection and Multiple Sclerosis: A Review , 2010, Journal of Neuroimmune Pharmacology.

[59]  Xiaoli Yu,et al.  Viruses and multiple sclerosis. , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.